Correlation Between Genetic Technologies and Elevate Uranium

Can any of the company-specific risk be diversified away by investing in both Genetic Technologies and Elevate Uranium at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genetic Technologies and Elevate Uranium into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Genetic Technologies and Elevate Uranium, you can compare the effects of market volatilities on Genetic Technologies and Elevate Uranium and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genetic Technologies with a short position of Elevate Uranium. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genetic Technologies and Elevate Uranium.

Diversification Opportunities for Genetic Technologies and Elevate Uranium

0.4

Correlation Coefficient

Genetic Technologies  Elevate Uranium

Very weak diversification

The 3 months correlation between Genetic and Elevate is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Genetic Technologies and Elevate Uranium in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevate Uranium and Genetic Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genetic Technologies are associated (or correlated) with Elevate Uranium. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevate Uranium has no effect on the direction of Genetic Technologies i.e., Genetic Technologies and Elevate Uranium go up and down completely randomly.

Pair Corralation between Genetic Technologies and Elevate Uranium

Assuming the 90 days trading horizon Genetic Technologies is expected to generate 0.41 times more return on investment than Elevate Uranium. However, Genetic Technologies is 2.44 times less risky than Elevate Uranium. It trades about 0.01 of its potential returns per unit of risk. Elevate Uranium is currently generating about -0.14 per unit of risk. If you would invest  3.90  in Genetic Technologies on September 29, 2024 and sell it today you would earn a total of  0.00  from holding Genetic Technologies or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Genetic Technologies  vs.  Elevate Uranium

Genetic Technologies

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Genetic Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Genetic Technologies is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Elevate Uranium

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Elevate Uranium has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Genetic Technologies and Elevate Uranium

The main advantage of trading using opposite Genetic Technologies and Elevate Uranium positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genetic Technologies position performs unexpectedly, Elevate Uranium can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevate Uranium will offset losses from the drop in Elevate Uranium's long position.

The idea behind Genetic Technologies and Elevate Uranium pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.